Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report

This article presented a case of a human leukocyte antigen (HLA)-A2-positive patient with advanced cancer/testis antigen New York esophageal squamous cell carcinoma-1 (NY-ESO-1) expressing lung adenocarcinoma (LADC) who received adoptive cell therapy of T cell receptor engineered-T cells (TCR-T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yan, Tian, Xiaopeng, Wang, Juntao, Qiao, Dongjuan, Liu, Xianhao, Xiao, Liang, Liang, Wenli, Ban, Dongcheng, Chu, Junjun, Yu, Jiaming, Wang, Rongfu, Tian, Geng, Wang, Mingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256329/
https://www.ncbi.nlm.nih.gov/pubmed/30546433
http://dx.doi.org/10.3892/ol.2018.9534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256329/
https://www.ncbi.nlm.nih.gov/pubmed/30546433
http://dx.doi.org/10.3892/ol.2018.9534

Ejemplares similares